de los Pinos Elisabet's most recent trade in Aura Biosciences Inc was a trade of 10,948 Common Stock done at an average price of $5.1 . Disclosure was reported to the exchange on June 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.07 per share. | 02 Jun 2025 | 10,948 | 493,388 | - | 5.1 | 55,506 | Common Stock |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 10,948 | 0 | - | - | Stock Option (Right to Buy) | |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.16 per share. | 02 Jun 2025 | 9,948 | 483,440 | - | 6.2 | 61,280 | Common Stock |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 7.75 per share. | 18 Feb 2025 | 20,221 | 482,440 | - | 7.8 | 156,796 | Common Stock |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 255,680 | 255,680 | - | - | Stock Option (Right to Buy) | |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 194,320 | 502,661 | - | 0 | Common Stock | |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 7.67 per share. | 21 Jan 2025 | 15,955 | 304,692 | - | 7.7 | 122,381 | Common Stock |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 10.74 per share. | 29 Oct 2024 | 9,200 | 320,647 | - | 10.7 | 98,788 | Common Stock |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Oct 2024 | 24,992 | 336,171 | - | - | Stock Option (Right to Buy) | |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 12.04 per share. | 18 Oct 2024 | 24,992 | 329,847 | - | 12.0 | 300,839 | Common Stock |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.74 per share. | 18 Oct 2024 | 24,992 | 354,839 | - | 2.7 | 68,478 | Common Stock |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.76 per share. | 27 Sep 2024 | 5,474 | 329,847 | - | 5.8 | 31,530 | Common Stock |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Sep 2024 | 5,474 | 0 | - | - | Stock Option (Right to Buy) | |
| Aura Biosciences Inc | de los Pinos Elisabet | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 237,065 | 237,065 | - | - | Stock Option (Right to Buy) | |
| Aura Biosciences Inc | de los Pinos Elisabet | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 162,935 | 324,373 | - | 0 | Common Stock | |
| Aura Biosciences Inc | de los Pinos Elisabet | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 7.64 per share. | 23 Jan 2024 | 15,853 | 161,438 | - | 7.6 | 121,141 | Common Stock |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2023 | 187,500 | 187,500 | - | - | Stock Option (Right to Buy) | |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2023 | 121,875 | 190,526 | - | 0 | Common Stock | |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 12.46 per share. | 31 Oct 2022 | 5,706 | 68,651 | - | 12.5 | 71,082 | Common Stock |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | 02 Nov 2021 | 4,552 | 131,412 | - | 0 | Common Stock | ||
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | 02 Nov 2021 | 3,042 | 0 | - | - | Series A-1 Preferred Stock | ||
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | 02 Nov 2021 | 1,510 | 0 | - | - | Series A-2 Preferred Stock |